Valneva SE VALN
NASDAQ VALN
$5.80 -0.10 (-1.68%)
As of: Oct 2, 2026 · 12:46 PM EDT

Valneva SE (VALN) Non-Current Deffered Revenue (2020 - 2022)

Updated

Valneva SE's Non-Current Deffered Revenue was -$5.35 million in Q4 2022, compared with $5.33 million a year earlier.

Analysis

Valneva SE (VALN) Non-Current Deffered Revenue (2020 - 2022) Analysis & Trends

  • In earlier years, Non-Current Deffered Revenue was $5.52 million in FY2021 and -$769,556 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Valneva SE 536.24 Mn -23.65 Mn 1.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -5.35 Mn
Dec 31, 2021 5.33 Mn
Dec 31, 2020 -803,603.36
API Access

Valneva SE Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VALN&period=max&api_key=YOUR_API_KEY